XERIS BIOPHARMA HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.33 USD | -1.27% |
|
+3.33% | -0.85% |
| May. 30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
| May. 30 | Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 345M | - | - | - | |||
| 765B | ||||||
| 354B | - | - | - | - | ||
| 331B | ||||||
| 299B | ||||||
| 248B |
